|
Volumn 13, Issue 6, 2007, Pages 681-684
|
The US pandemic influenza implementation plan at six months
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
HEMAGGLUTININ;
IMMUNOLOGICAL ADJUVANT;
INFLUENZA VACCINE;
OSELTAMIVIR;
RECOMBINANT VACCINE;
SIALIDASE INHIBITOR;
ZANAMIVIR;
COST BENEFIT ANALYSIS;
ECONOMIC ASPECT;
GOVERNMENT;
HEALTH CARE PERSONNEL;
HEALTH PROGRAM;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
NOTE;
PANDEMIC;
POULTRY FARMING;
PRIORITY JOURNAL;
UNITED STATES;
DISEASE OUTBREAKS;
HUMANS;
INFLUENZA, HUMAN;
UNITED STATES;
|
EID: 34250016564
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1597 Document Type: Note |
Times cited : (10)
|
References (21)
|